Adma Biologics, Inc.
ADMA· Nasdaq
Released Aug 12, 2013, after the close
10-Q filed Aug 12, 2013, 43 days after period end · 0001193805-13-001413
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | $743.27K | $230.10K | — |
| Net Income | -$4.90M | -$1.21M | -$2.39M |
| EPS Diluted | -$0.83 | -$0.20 | -$6.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR